mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.01 |
mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.01 |
mRNA |
ZM-447439 |
GDSC1000 |
pan-cancer |
AAC |
0.088 |
0.01 |
mRNA |
docetaxel:tanespimycin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.01 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
linifanib |
GDSC1000 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
SJ-172550 |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.02 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.02 |
mRNA |
PLX4720 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |